Antitumor effects of apoptin expressed by the dual cancer-specific oncolytic adenovirus - a review

被引:5
|
作者
Fang, J-B [1 ]
Zhu, G-Z [1 ]
Zhu, Y-L [1 ]
Li, Y-Q [1 ]
Shang, C. [2 ]
Bai, B. [1 ]
Jin, N-Y [1 ,2 ]
Li, X. [1 ,2 ]
机构
[1] Changchun Univ Chinese Med, Academician Workstn Jilin Prov, Changchun, Jilin, Peoples R China
[2] Acad Mil Med Sci, Inst Mil Vet Med, Lab Mol Virol & Immunol, Changchun, Jilin, Peoples R China
关键词
Apoptin; Cancer; Apoptosis; Phosphorylation; Oncolytic adenovirus; CHICKEN ANEMIA VIRUS; PROTEIN APOPTIN; CELL-DEATH; IN-VIVO; APOPTOSIS; INDUCTION; PHOSPHORYLATION; BCL-2; AKT; CONSTRUCTION;
D O I
10.26355/eurrev_202011_23624
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apoptin is a small molecular weight protein derived from chicken anemia virus. which can induce the apoptosis of transformed cells and tumor cells and leave primary and nontransformed cells unharmed. Apoptin's cell localization depends on its own phosphorylation state and cell type. In tumor cells, phosphorylated apoptin enters the nucleus and induces apoptosis. While, in normal cells apoptin mainly exists in the cytoplasm. Apoptin, as a disordered protein in cells, interacts with many proteins in cell signal pathways to induce apoptosis of tumor cells. The specific mechanism of apoptosis induced by apoptin has not been completely elucidated. Therefore. apoptin has become a potential anticancer agent. This review summarizes the research results of apoptin in our laboratory and reveals the specific antitumor mechanism of apoptin expressed by oncolytic virus vector on a variety of tumor cells and mouse models.
引用
收藏
页码:11334 / 11343
页数:10
相关论文
共 50 条
  • [21] Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer
    Ma, Shuai
    Qu, Wenzhi
    Mao, Liang
    Zhu, Zhi
    Jia, Lanling
    Zhao, Lei
    Zheng, Xinyu
    ONCOLOGY REPORTS, 2012, 27 (05) : 1443 - 1450
  • [22] A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro
    Tian, Yufei
    Yao, Wei
    He, Dongyun
    Xu, Yingying
    Li, Yiquan
    Zhu, Yilong
    Fang, Jinbo
    Bai, Bing
    Li, Xiao
    Sun, Lili
    Jin, Ningyi
    ANTI-CANCER DRUGS, 2020, 31 (02) : 110 - 122
  • [23] Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells
    Cui, Yingli
    Li, Yiquan
    Li, Shanzhi
    Li, Wenjie
    Zhu, Yilong
    Wang, Jing
    Liu, Xing
    Yue, Ying
    Jin, Ningyi
    Li, Xiao
    EXPERIMENTAL CELL RESEARCH, 2020, 396 (01)
  • [24] Oncolytic-adenovirus-expressed RNA interference for cancer therapy
    Pei, Dong-Sheng
    Di, Jie-Hui
    Chen, Fei-Fei
    Zheng, Jun-Nian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (09) : 1331 - 1341
  • [25] In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
    Li, Tingyu
    Fang, Jinbo
    Chu, Jihao
    Liu, Xing
    Li, Yiquan
    Zhu, Yilong
    Li, Shanzhi
    Xiu, Zhiru
    Li, Yaru
    Jin, Ningyi
    Zhu, Guangzhe
    Sun, Lili
    Li, Xiao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (05) : 1073 - 1085
  • [26] In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
    Tingyu Li
    Jinbo Fang
    Jihao Chu
    Xing Liu
    Yiquan Li
    Yilong Zhu
    Shanzhi Li
    Zhiru Xiu
    Yaru Li
    Ningyi Jin
    Guangzhe Zhu
    Lili Sun
    Xiao Li
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1073 - 1085
  • [27] Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer
    Wang, Jing
    Li, Yiquan
    Li, Shanzhi
    Yao, Wei
    Liu, Xing
    Zhu, Yilong
    Li, Wenjie
    Sun, Liankun
    Jin, Ningyi
    Li, Xiao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [28] Apoptotic and autophagic cell death induced in cervical cancer cells by a dual specific oncolytic adenovirus
    Li, Shanzhi
    Li, Zhuoxin
    Chen, Shuang
    Zhu, Yilong
    Li, Yiquan
    Yin, Xunzhe
    Li, Xiao
    Zhu, Guangze
    ANTI-CANCER DRUGS, 2023, 34 (03) : 361 - 372
  • [29] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Watanabe, Y.
    Hashimoto, Y.
    Kagawa, S.
    Kawamura, H.
    Nagai, K.
    Tanaka, N.
    Urata, Y.
    Fujiwara, T.
    CANCER GENE THERAPY, 2012, 19 (11) : 767 - 772
  • [30] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Y Watanabe
    Y Hashimoto
    S Kagawa
    H Kawamura
    K Nagai
    N Tanaka
    Y Urata
    T Fujiwara
    Cancer Gene Therapy, 2012, 19 : 767 - 772